MedTrace Logo

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma

NCT04528394 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2020-08-27

No results posted yet for this study

Summary

The purpose of this study is to compare the toxicity and therapeutic efficacy of proton or photon combined with carbon ion radiotherapy for newly diagnosed nasopharyngeal carcinoma.Participants will be randomized to 2 arms. Arm 1, participants received photon combined with carbon ion radiotherapy group, Arm 2, participants received proton combined with carbon ion radiotherapy.

Conditions

  • Nasopharyngeal Carcinoma

Interventions

RADIATION

Photon

Photon combined with Carbon ion in Arm 1

RADIATION

Proton

Proton combined with Carbon ion in Arm 2

RADIATION

Carbon ion

Same dose and fractionation will be used in both arms.

Sponsors & Collaborators

  • Shanghai Proton and Heavy Ion Center

    lead OTHER

Principal Investigators

  • Jiade Lu, MD · Shanghai Proton and Heavy Ion Center,Shanghai, SPHIC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-29
Primary Completion
2021-06-30
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04528394 on ClinicalTrials.gov